Cancer Genetics, Inc. Gains 74.93%

Wed, Jan 20, 2021 at 05:30 PM
Cancer Genetics, Inc. Gains 74.93%

Cancer Genetics, Inc. (CGIX:NASDAQ) rocketted at $5.86, a gain of 74.9%. The stock got featured on our News Catalysts scanner on Sat 16 Jan 21 at 03:27 PM in the 'MERGER' category. From Tue 05 Jan 21, the stock recorded 77.78% Up Days and 50.00% Green Days

The stock spiked on Tue 05 Jan 21 at $4.1 with a volume of 5M+, and its share price has been moving sideways in recent weeks.

About Cancer Genetics, Inc. (CGIX:NASDAQ)

Cancer Genetics Inc is an early-stage diagnostics company which develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.